Cellular functional experiments and animal models collectively revealed that the PHGDH enzyme-inactive mutant (V425M)32 and the PHGDH-ΔRBD mutant exhibited weaker promotion of HCC cell proliferation compared to the PHGDH WT. Here, PHGDH is linked to hepatocellular carcinoma.